New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
05:49 EDTAGNAllergan upgraded to Buy from Neutral at UBS
UBS upgraded Allergan to Buy citing expectations for an accretive acquisition and the company's "solid" cost cutting efforts. The firm raised its price target for shares to $200 from $180.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AGN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use